Bank Of America Corp Galecto, Inc. Call Options Transaction History
Bank Of America Corp
- $1.12 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding GLTO
# of Institutions
16Shares Held
1.28MCall Options Held
100Put Options Held
100-
Susquehanna International Group, LLP Bala Cynwyd, PA168KShares$1.16 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il129KShares$889,8010.0% of portfolio
-
State Street Corp Boston, MA44.9KShares$310,7490.0% of portfolio
-
Two Sigma Securities, LLC New York, NY27.1KShares$187,7810.0% of portfolio
-
Black Rock Inc. New York, NY21.2KShares$146,7380.0% of portfolio
About Galecto, Inc.
- Ticker GLTO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,395,700
- Market Cap $176M
- Description
- Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB0139, an inhaled inhibitor of galectin-3 that is in Phase IIb clini...